Pharma Wholesale and Distribution Market Report 2022-2032
Forecasts by Distributor Type (Ethical/Branded Pharma Products Distributors, Generic Pharma Products Distributors, Propaganda Cum Distribution (PCD) Franchise, OTC/Institutional Supply Pharma Distributors, Other), by Type (Full-Line Wholesalers (FLWs), Short-Line Wholesalers (SLWs), Direct-to-Pharmacy (DTP), Hospitals, Clinics & Others, Mail Orders, Other), by Product Type (Prescription Drugs Wholesaling & Distribution, Antibiotics Wholesaling & Distribution, OTC Products Wholesaling & Distribution, Antiseptics Wholesaling & Distribution, Supplement Products Wholesaling & Distribution, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Pharma Wholesale and Distribution Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Pharmaceutical Wholesaler and Distributor Anticipated to Meet the Needs of Ongoing & Changing Need for Healthcare Sector Pharmaceutical wholesaler and distributor are anticipated to meet the needs of the new worldwide market prospects brought on by an ongoing and changing need for healthcare sector. The pharmaceutical industry has traditionally played a significant role in meeting the distribution demands of pharmaceutical businesses. The pharmaceutical business is vast. The pharmaceutical industry is mainly focused on retail, and the majority of businesses are dispersed. The majority of pharmaceutical companies offer their goods in their own nationwide centres. Due to growing market demands, the sector is continually evolving. Pharmaceutical producers sell their products directly to wholesale drug wholesalers. Pharmacy purchases the drugs from the wholesale distributor of pharmaceuticals. Pharmaceutical distributors who offer full service provide their customers with a range of goods and services to fulfil their demands. Independent pharmacists and home care businesses can save money and important time by working with a pharmaceutical source that offers goods like wholesale medications and over-the-counter painkillers.
To Increase Productivity, Businesses Must Spend Money on Monitoring Software to Avoid Interruption of the Supply Chain In any industry, the supply chain can experience issues. Supply networks have experienced an unprecedented upheaval globally. In actuality, this is one of the biggest issues facing the pharmaceutical industry right now. Although pharmaceutical company management works hard to optimise processes for maximum effectiveness, unforeseen technological issues could cause the entire industry to be delayed. As a result, they modify their strategy and employ their resources to lessen the issues throughout the supply chain. Businesses must invest in monitoring software if they want to increase productivity. In actuality, the monitoring software will help in locating the items and assessing the supply chain’s condition.
What Questions Should You Ask before Buying a Market Research Report? • How is the pharma wholesale and distribution market evolving? • What is driving and restraining the pharma wholesale and distribution market? • How will each pharma wholesale and distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032? • How will the market shares for each pharma wholesale and distribution submarket develop from 2022 to 2032? • What will be the main driver for the overall market from 2022 to 2032? • Will leading pharma wholesale and distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032? • Who are the leading players and what are their prospects over the forecast period? • What are the pharma wholesale and distribution projects for these leading companies? • How will the industry evolve during the period between 2022 and 2032? What are the implications of pharma wholesale and distribution projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the pharma wholesale and distribution market? • Where is the pharma wholesale and distribution market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the pharma wholesale and distribution market today, and over the next 10 years: • Our 362-page report provides 176 tables and 149 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the pharma wholesale and distribution market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma wholesale and distribution prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Distributor Type • Ethical/Branded Pharma Products Distributors • Generic Pharma Products Distributors • Propaganda Cum Distribution (PCD) Franchise • OTC/Institutional Supply Pharma Distributors • Other Distributor Types
Type • Full-Line Wholesalers (FLWs) • Short-Line Wholesalers (SLWs) • Direct-to-Pharmacy (DTP) • Hospitals, Clinics & Others • Mail Orders • Other Types
Product Type • Prescription Drugs Wholesaling & Distribution • Antibiotics Wholesaling & Distribution • OTC Products Wholesaling & Distribution • Antiseptics Wholesaling & Distribution • Supplement Products Wholesaling & Distribution • Other Product Types
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:
North America • U.S. • Canada
Europe • Germany • France • UK • Italy • Spain • Russia • UK • The Netherlands • Denmark • Finland • Rest of Europe
Asia Pacific • China • India • Japan • South Korea • Australia • Indonesia • Malaysia • Rest of Asia Pacific
Latin America • Brazil • Mexico • Argentina • Rest of Latin America
MEA • Saudi Arabia • Turkey • UAE • South Africa • Rest of MEA
The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Alfresa Holdings • AmerisourceBergen Corporation • Cardinal Health, Inc. • China Resources Pharmaceutical Group Limited • CuraScript SD • Dakota Drug Inc. • Fortissa • Fosun International • Geo-Young Corporation • Kingworld Medicines Group Ltd. • Mawdsley-Brooks • McKesson Corporation • Medipal Holdings Corporation • Morris and Dickson • Mutual Drug Company • Ohki Healthcare Holdings Co., Ltd • Petrone Group • PHOENIX Group • Prodigy Health • Profarma Distribuidora de Produtos Farmaceuticos SA • Realcan Pharmaceutical Group Co. • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. • Sinopharm Group Co. Ltd. • Smith Drug Company • Suzuken Co Ltd. • Walgreens Boots Alliance, Inc. • Zhejiang Int’l Group Co. Ltd
Overall world revenue for Pharma Wholesale and Distribution Market, 2022 to 2032 in terms of value the market will surpass US$548 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Pharma Wholesale and Distribution Market, 2022 to 2032 report help you? In summary, our 360+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Pharma Wholesale and Distribution Market, 2022 to 2032 Market, with forecasts for product type, distributor type, and type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for five regional and 20 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and Latin America and MEA Also forecasted is the market in the U.S. , Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 27 of the major companies involved in the Pharma Wholesale and Distribution Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Buy our report today Pharma Wholesale and Distribution Market Report 2022-2032: Forecasts by Distributor Type (Ethical/Branded Pharma Products Distributors, Generic Pharma Products Distributors, Propaganda Cum Distribution (PCD) Franchise, OTC/Institutional Supply Pharma Distributors, Other), by Type (Full-Line Wholesalers (FLWs), Short-Line Wholesalers (SLWs), Direct-to-Pharmacy (DTP), Hospitals, Clinics & Others, Mail Orders, Other), by Product Type (Prescription Drugs Wholesaling & Distribution, Antibiotics Wholesaling & Distribution, OTC Products Wholesaling & Distribution, Antiseptics Wholesaling & Distribution, Supplement Products Wholesaling & Distribution, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview 1.1 Objectives of the Study 1.2 Introduction to Pharma Wholesale and Distribution Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report Include: 1.6 Who is This Report For? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.5.1 Primary Research 1.7.5.1 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Structure 3.1 Supply Chain 3.1.5.1 Growth and Complexity 3.1.5.1 Infrastructure improvement: Self-care for Expanding Supply Chains 3.1.5.1 From Raw Data to Meaningful Insights, Complexity is Decreasing 3.1.5.1 Driving Performance: Aligned Business Drivers 3.1.5.1 Utilising Resources from External Consultancies 3.2 Value Chain 3.2.5.1 Producing the Medicines 3.2.5.1 Distribution to the Dispensing Point 3.2.5.1 Dispensing to the end user 3.3 Recent Trends/ Developments 3.3.5.1 Artificial Intelligence (AI) 3.3.5.1 Analytics & Big Data 3.3.5.1 Medical Precision 3.3.5.1 Dynamic Production 3.3.5.1 Therapeutic Procedures
4 Market Overview 4.1 Market Dynamics 4.2 Market Driving Factors 4.2.1 Diseases Caused by Pollution 4.2.2 Adapting To New Lifestyles 4.2.1 Increase In Maintenance and Cost Control 4.3 Market Restraining Factors 4.3.1 Supply Chain Disruptions Involving A Single or Double Source Have A Greater Impact On The Market 4.3.2 Distributors Must Possess a Licence in Order to Be An Authorized Trading Partner 4.3.3 Pharmacological And Physical Restraints in Hospital Care 4.4 Market Opportunities 4.4.1 From Raw Data to Operating Analytics, Complexity Decreases 4.4.2 Utilizing External Consulting Services 4.4.3 Growth Owing to a Rise in Subsidized Spending Through Programs 4.5 Market Challenges 4.5.1 Large-Scale Data Gathering and Analysis 4.5.2 Interruption of The Supply Chain 4.5.3 Increasing Customer Demands and Challenges in Maintaining Brand Health 4.6 COVID-19 Impact Analysis 4.7 SWOT Analysis 4.7.1 Market Strengths 4.7.2 Market Weaknesses 4.7.3 Market Opportunities 4.7.4 Market Threats 4.8 Porter’s Five Forces Analysis 4.8.1 Supplier Power 4.8.2 Buyer Power 4.8.3 Competitive Rivalry 4.8.4 Threat from Substitutes 4.8.5 Threat of New Entrants 4.9 PESTLE Analysis 4.9.1 Political Factors 4.9.2 Economic Factors 4.9.3 Social Factors 4.9.4 Technology Factors 4.9.5 Legal Factors 4.9.6 Environmental Factors
5 Pharma Wholesale and Distribution Market Analysis 5.1 Pharma Wholesale and Distribution Overview 5.2 Pharmaceutical Manufacturing Market 5.3 Logistic Distribution of Pharmaceutical Market 5.4 Subdivisions of The World Pharma Business
6 Pharma Wholesale and Distribution Market Analysis by Type 6.1 Segment Overview 6.1.1 Full-Line Wholesalers (FLWs) 6.1.2 Short-Line Wholesalers (SLWs) 6.1.3 Direct-to-Pharmacy (DTP) 6.1.4 Hospitals, Clinics & Others 6.1.5 Mail Orders 6.1.6 Other Types 6.2 Market Size Estimation and Forecast by Type
7 Pharma Wholesale and Distribution Market Analysis by Product Type 7.1 Segment Overview 7.1.1 Prescription Drugs Wholesaling & Distribution 7.1.2 OTC Products Wholesaling & Distribution 7.1.3 Antibiotics Wholesaling & Distribution 7.1.4 Antiseptics Wholesaling & Distribution 7.1.5 Supplement Products Wholesaling & Distribution 7.1.6 Other Product Types 7.2 Market Size Estimation and Forecast by Product Type
8 Pharma Wholesale and Distribution Market Analysis by Distributor Type 8.1 Segment Overview 8.1.1 Ethical/Branded Pharma Products Distributors 8.1.2 Generic Pharma Products Distributors 8.1.3 Propaganda Cum Distribution (PCD) Franchise 8.1.4 OTC/Institutional Supply Pharma Distributors 8.1.5 Other Distributor Types 8.2 Market Size Estimation and Forecast by Distributor Type
9 North America Pharma Wholesale and Distribution Market Analysis 9.1 North America Market Size Estimation and Forecast by Value 9.2 Market Size Estimation and Forecast by Country 9.3 Market Size Estimation and Forecast by Product Type 9.4 Market Size Estimation and Forecast by Distributor Type 9.5 Market Size Estimation and Forecast by Type 9.6 U.S. Market Analysis 9.7 Canada Market Analysis
10 Europe Pharma Wholesale and Distribution Market Analysis 10.1 Europe Market Outlook 10.2 Market Size Estimation and Forecast by Value 10.3 Market Size Estimation and Forecast by Country 10.4 Market Size Estimation and Forecast by Product Type 10.5 Market Size Estimation and Forecast by Distributor Type 10.6 Market Size Estimation and Forecast by Type 10.7 Germany Market Analysis 10.8 France Market Analysis 10.9 UK Market Analysis 10.10 Italy Market Analysis 10.11 Spain Market Analysis 10.12 Finland Market Analysis 10.13 Russia Market Analysis 10.14 The Netherlands Market Analysis 10.15 Denmark Market Analysis 10.16 Rest of Europe Market Analysis
11 Asia-Pacific Pharma Wholesale and Distribution Market Analysis 11.1 Asia- Pacific Market Outlook 11.2 Market Size Estimation and Forecast by Value 11.3 Market Size Estimation and Forecast by Country 11.4 Market Size Estimation and Forecast by Product Type 11.5 Market Size Estimation and Forecast by Distributor Type 11.6 Market Size Estimation and Forecast by Type 11.7 China Market Analysis 11.8 India Market Analysis 11.9 Japan Market Analysis 11.10 South Korea Market 11.11 Australia Market Analysis 11.12 Indonesia Market Analysis 11.13 Malaysia Market Analysis 11.14 Rest of Asia-Pacific Market Analysis
12 Latin America Pharma Wholesale and Distribution Market Analysis 12.1 Latin America Outlook 12.2 Market Size Estimation and Forecast by Value 12.3 Market Size Estimation and Forecast by Country 12.4 Market Size Estimation and Forecast by Product Type 12.5 Market Size Estimation and Forecast by Distributor Type 12.6 Market Size Estimation and Forecast by Type 12.7 Brazil Market Analysis 12.8 Mexico Market Analysis 12.9 Argentina Market Analysis 12.10 Rest of Latin America Market Analysis
13 Middle East & Africa Pharma Wholesale and Distribution Market Analysis 13.1 Middle East & Africa Market Outlook 13.2 Market Size Estimation and Forecast by Value 13.3 Market Size Estimation and Forecast by Country 13.4 Market Size Estimation and Forecast by Product Type 13.5 Market Size Estimation and Forecast by Distributor Type 13.6 Market Size Estimation and Forecast by Type 13.7 Saudi Arabia Market Analysis 13.8 Turkey Market Analysis 13.9 UAE Market Analysis 13.10 South Africa Market Analysis 13.11 Rest of Middle East and Africa Market Analysis
14 Company Profiles 14.1 Strategic Framework 14.2 Morris and Dickson 14.2.1 Company Snapshot 14.2.2 Company Overview 14.2.3 Financial Analysis 14.2.4 Company Product Benchmarking 14.2.5 Strategic Outlook 14.3 Alfresa Holdings 14.3.1 Company Snapshot 14.3.2 Company Overview 14.3.3 Financial Analysis 14.3.4 Company Product Benchmarking 14.3.5 Strategic Outlook 14.4 Walgreens Boots Alliance, Inc 14.4.1 Company Snapshot 14.4.2 Company Overview 14.4.3 Financial Analysis 14.4.4 Company Product Benchmarking 14.4.5 Strategic Outlook 14.5 AmerisourceBergen Corporation 14.5.1 Company Snapshot 14.5.2 Company Overview 14.5.3 Financial Analysis 14.5.4 Company Product Benchmarking 14.5.5 Strategic Outlook 14.6 Sinopharm Group Co. Ltd 14.6.1 Company Snapshot 14.6.2 Company Overview 14.6.3 Financial Analysis 14.6.4 Company Product Benchmarking 14.6.5 Strategic Outlook 14.7 Suzuken Co Ltd 14.7.1 Company Snapshot 14.7.2 Company Overview 14.7.3 Financial Analysis 14.7.4 Company Product Benchmarking 14.7.5 Strategic Outlook 14.8 Shanghai Fosun Pharmaceutical (Group) Co., Ltd 14.8.1 Company Snapshot 14.8.2 Company Overview 14.8.3 Financial Analysis 14.8.4 Company Product Benchmarking 14.8.5 Strategic Outlook 14.9 China Resources Pharmaceutical Group Limited 14.9.1 Company Snapshot 14.9.2 Company Overview 14.9.3 Financial Analysis 14.9.4 Company Product Benchmarking 14.9.5 Strategic Outlook 14.10 Smith Drug Company 14.10.1 Company Snapshot 14.10.2 Company Overview 14.10.3 Company Product Benchmarking 14.11 CuraScript SD 14.11.1 Company Snapshot 14.11.2 Company Overview 14.11.3 Company Product Benchmarking 14.12 Cardinal Health, Inc. 14.12.1 Company Snapshot 14.12.2 Company Overview 14.12.3 Financial Analysis 14.12.4 Company Product Benchmarking 14.12.5 Strategic Outlook 14.13 Fosun International 14.13.1 Company Snapshot 14.13.2 Company Overview 14.13.3 Financial Analysis 14.13.4 Product Benchmarking 14.13.5 Strategic Outlook 14.14 Mutual Drug Company 14.14.1 Company Snapshot 14.14.2 Company Overview 14.14.3 Company Product Benchmarking 14.15 McKesson Corporation 14.15.1 Company Snapshot 14.15.2 Company Overview 14.15.3 Financial Analysis 14.15.4 Company Product Benchmarking 14.15.5 Strategic Outlook 14.16 Medipal Holdings Corporation 14.16.1 Company Snapshot 14.16.2 Company Overview 14.16.3 Financial Analysis 14.16.4 Company Product Benchmarking 14.16.5 Strategic Outlook 14.17 PHOENIX Group 14.17.1 Company Snapshot 14.17.2 Company Overview 14.17.3 Financial Analysis 14.17.4 Company Product Benchmarking 14.17.5 Strategic Outlook 14.18 Mawdsley-Brooks 14.18.1 Company Snapshot 14.18.2 Company Overview 14.18.3 Company Product Benchmarking 14.19 Prodigy Health 14.19.1 Company Snapshot 14.19.2 Company Overview 14.19.3 Company Product Benchmarking 14.20 Geo-Young Corporation 14.20.1 Company Snapshot 14.20.2 Company Overview 14.20.3 Product Benchmarking 14.20.4 Strategic Outlook 14.21 Kingworld Medicines Group Ltd 14.21.1 Company Snapshot 14.21.2 Company Overview 14.21.3 Product Benchmarking 14.21.4 Strategic Outlook 14.22 Profarma Distribuidora de Produtos Farmaceuticos SA 14.22.1 Company Snapshot 14.22.2 Company Overview 14.22.3 Financial Analysis 14.22.4 Product Benchmarking 14.23 Petrone Group 14.23.1 Company Snapshot 14.23.2 Company Overview 14.23.3 Product Benchmarking 14.23.4 Strategic Outlook 14.24 Realcan Pharmaceutical Group Co 14.24.1 Company Snapshot 14.24.2 Company Overview 14.24.3 Financial Analysis 14.24.4 Product Benchmarking 14.24.5 Strategic Outlook 14.25 Dakota Drug Inc. 14.25.1 Company Snapshot 14.25.2 Company Overview 14.25.3 Product Benchmarking 14.26 Zhejiang Int’l Group Co. Ltd 14.26.1 Company Snapshot 14.26.2 Company Overview 14.26.3 Financial Analysis 14.26.4 Product Benchmarking 14.27 Ohki Healthcare Holdings Co., Ltd 14.27.1 Company Snapshot 14.27.2 Company Overview 14.27.3 Financial Analysis 14.27.4 Product Benchmarking 14.27.5 Strategic Outlook 14.28 Fortissa 14.28.1 Company Snapshot 14.28.2 Company Overview 14.28.3 Company Product Benchmarking
15 Conclusion and Recommendations
List of Tables Table 1 Pharma Wholesale and Distribution Market Snapshot, 2022 & 2032 (US$ billion, CAGR %) Table 2 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario) Table 3 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario) Table 4 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario) Table 5 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario) Table 6 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario) Table 7 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario) Table 8 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario) Table 9 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario) Table 10 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 11 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 12 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 13 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 14 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 15 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 16 Full-Line Wholesalers (FLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 17 Full-Line Wholesalers (FLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 18 Short-Line Wholesalers (SLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 19 Short-Line Wholesalers (SLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 20 Direct-to-Pharmacy (DTP) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 21 Direct-to-Pharmacy (DTP) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 22 Hospitals, Clinics & Others Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 23 Hospitals, Clinics & Others Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 24 Mail Orders Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 25 Mail Orders Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 26 Other Types Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 27 Other Types Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 28 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 29 Prescription Drugs Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 30 Prescription Drugs Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 31 Antibiotics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 32 Antibiotics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 33 OTC Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 34 OTC Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 35 Antiseptics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 36 Antiseptics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 37 Supplement Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 38 Supplement Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 39 Other Product Types Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 40 Other Product Types Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 41 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 42 Ethical/Branded Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 43 Ethical/Branded Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 44 Generic Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 45 Generic Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 46 Propaganda Cum Distribution (PCD) Franchise Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 47 Propaganda Cum Distribution (PCD) Franchise Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 48 OTC/Institutional Supply Pharma Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 49 OTC/Institutional Supply Pharma Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 50 Other Distributor Types Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 51 Other Distributor Types Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 52 North America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 53 North America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 54 North America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 55 North America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 56 North America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 57 US Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 58 Canada Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 59 Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 60 Europe Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 61 Europe Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 62 Europe Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 63 Europe Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 64 Germany Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 65 France Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 66 UK Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 67 Italy Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 68 Spain Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 69 Finland Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 70 Russia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 71 The Netherlands Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 72 Denmark Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 73 Rest of Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 74 Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 75 Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 76 Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 77 Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 78 Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 79 China Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 80 India Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 81 Japan Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 82 South Korea Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 83 Australia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 84 Indonesia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 85 Malaysia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 86 Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 87 Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 88 Latin America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 89 Latin America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 90 Latin America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 91 Latin America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 92 Brazil Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 93 Mexico Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 94 Argentina Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 95 Rest of Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 96 Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 97 Middle East & Africa Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 98 Middle East & Africa Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 99 Middle East & Africa Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 100 Middle East & Africa Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 101 Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 102 Turkey Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 103 UAE Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 104 South Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 105 Rest of Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) Table 106 Strategic Framework Table 107 Morris and Dickson.: Company Information Table 108 Morris and Dickson.: Company Service Benchmarking Table 109 Morris and Dickson.: Strategic Outlook Table 110 Alfresa Holdings.: Company Information Table 111 Alfresa Holdings.: Company Service Benchmarking Table 112 Alfresa Holdings.: Strategic Outlook Table 113 Walgreens Boots Alliance, Inc: Company Information Table 114 Walgreens Boots Alliance, Inc: Company Product and Service Benchmarking Table 115 Walgreens Boots Alliance, Inc: Strategic Outlook Table 116 AmerisourceBergen Corporation.: Company Information Table 117 AmerisourceBergen Corporation.: Company Product and Service Table 118 AmerisourceBergen Corporation Strategic Outlook Table 119 Sinopharm Group Co. Ltd: Company Information Table 120 Sinopharm Group Co. Ltd: Company Product and Service Table 121 Sinopharm Group Co. Ltd.: Strategic Outlook Table 122 Suzuken Co Ltd : Company Information Table 123 Suzuken Co Ltd : Company Product and Service Benchmarking Table 124 Suzuken Co Ltd: Strategic Outlook Table 125 Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Information Table 126 Suzuken Co Ltd : Company Product and Service Benchmarking Table 127 Shanghai Fosun Pharmaceutical (Group) Co., Ltd .: Strategic Outlook Table 128 China Resources Pharmaceutical Group Limited.: Company Information Table 129 China Resources Pharmaceutical Group Limited.: Company Service Benchmarking Table 130 China Resources Pharmaceutical Group Limited.: Strategic Outlook Table 131 Smith Drug Company: Company Information Table 132 Smith Drug Company : Company Product and Service Benchmarking Table 133 CuraScript SD.: Company Information Table 134 CuraScript SD.: Company Product and Service Benchmarking Table 135 Cardinal Health, Inc.: Company Information Table 136 Cardinal Health, Inc.: Company Product and Service Benchmarking Table 137 Cardinal Health, Inc. Recent Developments Table 138 Fosun International: Company Information Table 139 Fosun International: Product Benchmarking Table 140 Fosun International: Strategic Outlook Table 141 Mutual drug Company: Company Information Table 142 Mutual drug Company: Company Product and Service Benchmarking Table 143 McKesson Corporation.: Company Information Table 144 McKesson Corporation: Product and Service Table 145 McKesson Corporation: Recent Developments Table 146 Medipal Holdings Corporation: Company Information Table 147 Medipal Holdings Corporation: Company Product and Service Table 148 Medipal Holdings Corporation.: Strategic Outlook Table 156 Geo-Young Corporation: Company Information Table 157 Geo-Young Corporation: Product Benchmarking Table 158 Geo-Young Corporation: Strategic Outlook Table 159 Kingworld Medicines Group Ltd: Company Information Table 160 Kingworld Medicines Group Ltd: Product Benchmarking Table 161 Kingworld Medicines Group Ltd: Strategic Outlook Table 162 Profarma Distribuidora de Produtos Farmaceuticos: Company Information Table 163 Profarma Distribuidora de Produtos Farmaceuticos SA: Product Benchmarking Table 164 Petrone Group: Company Information Table 165 Petrone Group: Product Benchmarking Table 166 Petrone Group: Strategic Outlook Table 167 Realcan Pharmaceutical Group Co: Company Information Table 168 Realcan Pharmaceutical Group Co: Product Benchmarking Table 169 Realcan Pharmaceutical Group Co: Strategic Outlook Table 170 Dakota Drug Inc.: Company Information Table 171 Dakota Drug Inc.: Product Benchmarking Table 172 Zhejiang Int’l Group Co. Ltd: Company Information Table 173 Zhejiang Int’l Group Co. Ltd: Product Benchmarking Table 174 Ohki Healthcare Holdings Co., Ltd: Company Information Table 175 Ohki Healthcare Holdings Co., Ltd: Product Benchmarking Table 176 Ohki Healthcare Holdings Co., Ltd: Strategic Outlook
List of Figures Figure 1 Pharma Wholesale and Distribution Market Segmentation Figure 2 Pharma Wholesale and Distribution Market Forecast by Region: Market Attractiveness Index Figure 3 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index Figure 4 Pharma Wholesale and Distribution Market by Distributor Type: Market Attractiveness Index Figure 5 Schematic of levels of pharmaceutical supply chains in emerging markets. Figure 6 Schematic of three main types of pharmaceutical value chains in emerging markets. Figure 7 Pharma Wholesale and Distribution Market: Market Dynamics Figure 8 COVID Impact Analysis: Pharma Wholesale and Distribution Market Recovery Scenarios Figure 9 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (V-Shaped Recovery Scenario) Figure 10 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (V-Shaped Recovery Scenario) Figure 11 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (W-Shaped Recovery Scenario) Figure 12 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (W-Shaped Recovery Scenario) Figure 13 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (U-Shaped Recovery Scenario) Figure 14 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (U-Shaped Recovery Scenario) Figure 15 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (L-Shaped Recovery Scenario) Figure 16 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (L-Shaped Recovery Scenario) Figure 17 Pharma Wholesale and Distribution Market: Porter’s Five Forces Analysis Figure 18 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 19 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 20 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 21 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 22 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 23 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 24 Full-Line Wholesalers (FLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 25 Full-Line Wholesalers (FLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 26 Short-Line Wholesalers (SLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 27 Short-Line Wholesalers (SLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 28 Direct-to-Pharmacy (DTP) Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 29 Direct-to-Pharmacy (DTP) Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 30 Hospitals, Clinics & Others Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 31 Hospitals, Clinics & Others Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 32 Mail Orders Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 33 Mail Orders Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 34 Other Types Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 35 Other Types Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 36 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 37 Prescription Drugs Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 38 Prescription Drugs Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 39 Antibiotics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 40 Antibiotics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 41 OTC Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 42 OTC Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 43 Antiseptics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 44 Antiseptics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 45 Supplement Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 46 Supplement Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 47 Other Product Types Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 48 Other Product Types Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 49 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 50 Ethical/Branded Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 51 Ethical/Branded Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 52 Generic Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 53 Generic Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 54 Propaganda Cum Distribution (PCD) Franchise Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 55 Propaganda Cum Distribution (PCD) Franchise Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 56 OTC/Institutional Supply Pharma Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 57 OTC/Institutional Supply Pharma Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 58 Other Distributor Types Market Forecast, 2022-2032 (US$ Bn, AGR (%)) Figure 59 Other Distributor Types Market by Region, 2022-2032 (US$ Bn, AGR (%)) Figure 60 North America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 61 North America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%)) Figure 62 North America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 63 North America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 64 North America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 65 US Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 66 Canada Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 67 Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 68 Europe Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%)) Figure 69 Europe Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 70 Europe Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 71 Europe Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 72 Germany Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 73 France Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 74 UK Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 75 Italy Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 76 Spain Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 77 Finland Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 78 Russia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 79 The Netherlands Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 80 Denmark Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 81 Rest of Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 82 Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 83 Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%)) Figure 84 Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 85 Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 86 Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 87 China Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 88 India Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 89 Japan Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 90 South Korea Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 91 Australia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 92 Indonesia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 93 Malaysia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 94 Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 95 Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 96 Latin America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%)) Figure 97 Latin America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 98 Latin America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 99 Latin America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 100 Brazil Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 101 Mexico Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 102 Argentina Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 103 Rest of Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 104 Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 105 Middle East & Africa Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%)) Figure 106 Middle East & Africa Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%)) Figure 107 Middle East & Africa Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%)) Figure 108 Middle East & Africa Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%)) Figure 109 Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 110 Turkey Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 111 UAE Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 112 South Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 113 Rest of Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%)) Figure 114 Morris and Dickson.: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 115 Alfresa Holdings.: Company Revenue 2018-2022 (US$Mn, AGR %) Figure 116 Alfresa Holdings.: Company Gross Profit 2018-2022 (US$Mn, AGR %) Figure 117 Alfresa Holdings.: Company R&D Expenses 2018-2022 (US$Mn, AGR %) Figure 118 Walgreens Boots Alliance, Inc: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 119 Walgreens Boots Alliance, Inc: Company Gross Profit- 2017-2021 (US$Mn, AGR %) Figure 120 AmerisourceBergen Corporation.: Company Revenue 2017-2021(US$Mn, AGR %) Figure 121 AmerisourceBergen Corporation.: Company Gross Profit 2017-2021(US$Mn, AGR %) Figure 122 Sinopharm Group Co. Ltd: Company Revenue 2017-2021(US$Mn, AGR %) Figure 123 Sinopharm Group Co. Ltd: Company Gross Profit 2017-2021(US$Mn, AGR %) Figure 124 Suzuken Co Ltd: Company Revenue 2018-2022 (US$Mn, AGR %) Figure 125 Suzuken Co Ltd: Company Gross Profit 2018-2022 (US$Mn, AGR %) Figure 126 Suzuken Co Ltd. : Company R & D Expenses 2018-2022 (US$Mn, AGR %) Figure 127 Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Revenue 2017-2021(US$Mn, AGR %) Figure 128 Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Gross Profit 2017-2021(US$Mn, AGR %) Figure 129 Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company R& D Expenses 2017-2021(US$Mn, AGR %) Figure 130 China Resources Pharmaceutical Group Limited.: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 131 China Resources Pharmaceutical Group Limited.: Company Gross Profit 2017-2021 (US$Mn, AGR %) Figure 132 China Resources Pharmaceutical Group Limited.: Company R & D Expenses 2017-2021 (US$Mn, AGR %) Figure 133 Cardinal Health, Inc.: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 134 Fosun International: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 135 Fosun International: R&D, 2017-2021 (US$ million, AGR%) Figure 136 McKesson Corporation: Revenue 2017-2022 (US$Mn, AGR %) Figure 137 McKesson Corporation: Gross Profit 2017-2022 (US$Mn, AGR %) Figure 138 Medipal Holdings Corporation: Revenue 2018-2022 (US$Mn, AGR %) Figure 139 Medipal Holdings Corporation: Gross Profit 2018-2022 (US$Mn, AGR %) Figure 140 PHOENIX Group.: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 141 Profarma Distribuidora de Produtos Farmaceuticos SA: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 142 Profarma Distribuidora de Produtos Farmaceuticos SA: Gross Profit, 2017-2021 (US$ million, AGR%) Figure 143 Realcan Pharmaceutical Group Co: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 144 Realcan Pharmaceutical Group Co: Gross Profit, 2017-2021 (US$ million, AGR%) Figure 145 Zhejiang Int’l Group Co. Ltd: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 146 Zhejiang Int’l Group Co. Ltd: Gross Profit, 2017-2021 (US$ million, AGR%) Figure 147 Zhejiang Int’l Group Co. Ltd: R&D, 2017-2021 (US$ million, AGR%) Figure 148 Ohki Healthcare Holdings Co., Ltd: Net Revenue, 2019-2022 (US$ million, AGR%) Figure 149 Ohki Healthcare Holdings Co., Ltd: Gross Profit, 2019-2022 (US$ million, AGR%)
List of Companies Profiled in the report Alfresa Holdings AmerisourceBergen Corporation Cardinal Health, Inc. China Resources Pharmaceutical Group Limited CuraScript SD Dakota Drug Inc. Fortissa Fosun International Geo-Young Corporation Kingworld Medicines Group Ltd. Mawdsley-Brooks McKesson Corporation Medipal Holdings Corporation Morris and Dickson Mutual Drug Company Ohki Healthcare Holdings Co., Ltd Petrone Group PHOENIX Group Prodigy Health Profarma Distribuidora de Produtos Farmaceuticos SA Realcan Pharmaceutical Group Co. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Sinopharm Group Co. Ltd. Smith Drug Company Suzuken Co Ltd. Walgreens Boots Alliance, Inc. Zhejiang Int’l Group Co. Ltd
List of Other Companies Mentioned in the report AAH Pharmaceuticals Ltd ALBA PHARMACEUTICALS SLU Alfa Chemicals Ltd AMBWholesale ANSPEC Pty Ltd Azwa Pharma CEPD N.V. CHAPPER healthcare China Meheco Crawford Healthcare CurePharma.co.uk Diprophar S.A. Distrimex Drogueria del Sud S.A. DynaMed EBOS Group Eurapharma Europarallel Fármacos Nacionales S.A. de C.V. Farmavox Firstline Pharma Ltd Iszipharm Pharmaceuticals Kohsar Distributors LEFRATIS Lemova pharma S.r.l. MANA PHARMA, S.L. Mayflax Medipal Holdings Corporation MMed Distribution Nakakita Yakuhin Co., Ltd. Oriola Corporation OTE Medical S.r.l. Pharma Division P&D Pharmaceuticals Parazelsus PB Pharma Canada Pelion SA Pharmakon LTD Prince Farma Protek Group Salehiya Medical SantaCruz Distribuidora Sinopharm Group SK-Pharma Taqwa Pharmaceutical & Surgical Toho Holdings Co., Ltd. Transpharm TruVic Private Ltd. TSUBAMEPharma United Italian Trading (M) Sdn Bhd (UITM) Zuellig Pharma Asia Pacific
List of Associations Mentioned in the Report African Pharmaceutical Distribution Association All Indian Origin Chemists & Distributors Ltd ( AIOCD Ltd) Association for Accessible Medicines (AAM) Association of the British Pharmaceutical Industry (ABPI) British Association of European Pharmaceutical Distributors (BAEPD) Canadian Association for Pharmacy Distribution Management (CAPDM) Canadian Generic Pharmaceutical Association (CGPA) Drug Information Association (DIA) European Federation of Pharmaceutical Industries and Associations (EFPIA) European Healthcare Distribution Association Healthcare Distribution Alliance (HDA) Healthcare Distribution Management Association Indian Pharmaceutical Association International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) International Society for Pharmaceutical Engineering (ISPE): IPEC Europe Kenya Pharmaceutical Distribution Association National Pharmaceutical Services Association (NPSA) Pharmaceutical Association of Malaysia (PhAMA) Pharmaceutical Research and Manufacturers of America (PhRMA) Singapore Association of Pharmaceutical Industries (SAPI)
Download sample pages
Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Report 2022-2032
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
